Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Vaccine

Biden's comments send Covid-19 vaccine maker stocks tumbling

US President Joe Biden's claim in a TV interview that "the pandemic is over" has triggered a sell-off, wiping over $10 billion off the market value of the main Covid-19 vaccine makers. Investors are worried about public apathy towards Covid and the resulting impact on demand for vaccines and boosters.…

France 24

How Biden's declaring the pandemic 'over' complicates efforts to fight COVID

Biden's comments — made as officials try to convince Americans to get a new booster shot and the White House seeks $22 billion in new COVID funding — were "unfortunate," several epidemiologists said.

WEKU

Nine Omicron symptoms affecting the fully vaccinated - and signs you may have it

Fainting and fatigue may signal onset of variant, experts say

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Experts alarmed by COVID vaccination rates among America's youngest kids

"What's at stake really with this is that we're going to be setting up a bunch of kids for risk of severe disease in the future."

Axios

A shot for good health

Coronavirus vaccines can reduce disease severity and fatality, but the emergence of new strains has raised questions about their effectiveness and future vaccination strategy. Some vaccine makers are rolling out variant-specific boosters to head off the Omicron surge, while others are developing pan-coronavirus vaccines that will hopefully offer protection against…

Bangkok Post

Canadian scientists made life-saving contributions during the COVID-19 pandemic

This year, the Nobel Prize in physiology or medicine will be awarded on Oct. 3. Canada will be in the spotlight again, thanks to Canadian scientists’ involvement with mRNA vaccine development.

The Conversation

Hero nurse who administered first Covid jab in UK walks behind Queen's coffin

Modern matron nurse May Parsons injected the first ever dose of the Pfizer vaccine into 90-year-old grandmother Maggie Keenan on December 8, 2020, at Coventry Hospital

Daily Mirror

Read news from The Economist, FT, and more,
with one subscription

With polio’s return, here’s what back-to-schoolers need to know

Before polio vaccines became available in the 1950s, people wary of the disabling disease were afraid to allow their children outside, let alone go to school. As polio appears again decades after it was considered eliminated in the U.S., Americans unfamiliar with the dreaded disease need a primer on protecting…

Tribune News Service

Spain holiday blow as 'easily missed' Covid rules to remain in place

Spain is one of the few European nations to continue the requirement for holidaymakers to be fully jabbed with the Covid-19 vaccine or to take a test prior to entry

Daily Mirror

With fall and cooler temps ahead, the new COVID booster is essential

Chicagoans, don’t allow COVID fatigue to keep you from staying safe and healthy. Take precautions against the coronavirus and the flu.

Chicago Sun-Times

Nine Omicron symptoms affecting the fully vaccinated - and signs you may have it

Fainting and fatigue may signal onset of variant, experts say

The Independent UK

Lumpy skin disease virus different from 2019 version

Finding raises questions about efficacy of the new vaccine

The Hindu

Fauci warns of anti-vaxxer attitude beyond COVID

WASHINGTON — President Joe Biden’s top medical adviser warned in an interview with the Financial Times that a broad refusal of vaccines against COVID-19 may undermine efforts to immunize children and contain future illness outbreaks.

Tribune News Service

Younger adults aren’t getting boosted — here’s why that could be a huge problem

Just because you aren't at high risk for Covid-19 doesn't mean you don't need a booster. An immunologist explains why boosters are key for healthy young adults.

Inverse

Get all your
news in one place.

100's of premium titles.
One news app.

Reuters

Brazil approves Pfizer vaccine for children as young as six months

Brazilian national health regulator Anvisa has approved the COVID-19 vaccine produced by Pfizer and BioNTech for children aged between six months and four years, the government body said in a statement Friday night.

Chicago Sun-Times

Nearly 200,000 Illinoisans have received the updated COVID booster

In Chicago, 65% of the doses administered to date have gone to white residents.

Wales Online

Wales sees another dramatic fall in its Covid infection rate but another part of the UK sees a rise

Less than 1% of the Welsh population now has Covid

Tribune News Service

Southern states’ lackluster monkeypox efforts leave LGBTQ+ groups going it alone

Dan DeChellis started looking for a monkeypox vaccine around July Fourth but was unable to find a place that offered one in Orlando, Florida, where he lives.

Get all your
news in one place.

100's of premium titles.
One news app.

Manchester Evening News

Where you can get the monkeypox vaccine in Greater Manchester next week

More clinics will run in the region over the next two weeks

Chicago Tribune

Commentary: Will vaccine fatigue affect how many people get the bivalent booster?

Pfizer’s and Moderna’s bivalent boosters, which are now available to many age groups, offer protection against the original COVID-19 virus plus the BA.4 and BA.5 omicron subvariants. Is the nation ready for yet another COVID-19 vaccine shot?

Los Angeles Times

Commentary: You might need a COVID booster yearly. But this virus is still nothing like the flu

Should everyone eligible get the new omicron-specific COVID booster? Yes, absolutely. But we should not get lulled into the illusion that the fight against COVID is over and now comparable to preventing the flu.

Benzinga

Important Biotech Catalysts For September 15, 2022 - End Of The Day Summary

Pfizer (NYSE:PFE) announced positive top-line results from the pivotal Phase 3 trial assessing the safety, tolerability, and immunogenicity of its investigational pentavalent meningococcal vaccine (MenABCWY) in healthy individuals 10 through 25 years of age. The trial met all primary and secondary endpoints. Pfizer shares traded in a range of $45.7…

ABC News

Queen Elizabeth II's death sparked a slew of misinformation. Here's what you need to know

Following the death of the Queen, rumours began to spread online on everything from the nature of her passing to the colour of the BBC's banner.

Bangkok Post

Breakthrough malaria shot needs more funding

It took scientists 30 years to create the first malaria vaccine, approved by the World Health Organization in 2021. A second, even better one is now almost ready to be deployed against the disease. Governments and philanthropies should be stepping up their funding to global health partners so they can…

StockNews.com

This 1 Stock Pays You Just for Owning It

Leading pharmaceutical company Pfizer (PFE) did exceptionally well during the pandemic thanks to the high demand for its COVID-19 vaccine, and it still has enough growth prospects. The company’s focus on strengthening its pipeline via business acquisitions, product development, and approvals is expected to deliver impressive growth in the upcoming…

1 … 186 187 188 189

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.